MedTrace Logo

Granulocyte Transfusion Study

NCT00000581 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2013-11-26

No results posted yet for this study

Summary

To evaluate granulocyte transfusion therapy with respect to its prophylactic and therapeutic effectiveness to prevent and aid recovery from infection. The study trials were conducted simultaneously.

Conditions

Interventions

PROCEDURE

leukocyte transfusions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Robert Gale · University of California

  • Geoffrey Herzig · Washington University School of Medicine

  • Ronald Strauss · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1976-09-30
Completion
1981-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000581 on ClinicalTrials.gov